Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9214-9220

  Khodarev, Nikolai N ^a   Minn, Andy J ^a   Efimova, Elena V ^a   Darga, Thomas E ^a   Labay, Edwardine ^a   Beckett, Michael ^a   Mauceri, Helena J ^a   Roizman, Bernard ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; STAT1 PROTEIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE ACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; RNA, SMALL INTERFERING; STAT1 TRANSCRIPTION FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 35148879113     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1019     Document Type: Article

References (52)

1. Mowen K, David M. Regulation of STAT1 nuclear export by Jak1. Mol Cell Biol 2000;20:7273-81.
2. Lodige I, Marg A, Wiesner B, Malecova B, Oelgeschlager T, Vinkemeier U. Nuclear export determines the cytokine sensitivity of STAT transcription factors. J Biol Chem 2005;280:43087-99.
3. Wang J, Campbell IL. Innate STAT1-dependent genomic response of neurons to the antiviral cytokine A interferon. J Virol 2005;79:8295-302.
4. Sanda C, Weitzel P, Tsukahara T, et al. Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res 2006;26:462-72.
5. Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE, Jr. ISGF3, the transcriptional activator induced by interferon α, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A 1990;87:8555-9.
6. Ahmed CM, Johnson HM. IFN-γ and its receptor subunit IFNGR1 are recruited to the IFN-γ-activated sequence element at the promoter site of IFN-γ-activated genes: evidence of transactivational activity in IFNGR1. J Immunol 2006;177:315-21.
7. Tessitore A, Pastore L, Rispoli A, et al. Two γ-interferon- activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-γ. Eur J Biochem 1998;258:968-75.
8. Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-62.
9. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778-809.
10. Min JY, Krug RM. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 2006;103:7100-5.
11. Carr DJ, Al-khatib K, James CM, Silverman R. Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J Neuroimmunol 2003;141:40-6.
12. Chawla-Sarkar M, Lindner DJ, Liu YF, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-49.
13. Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV-envelope proteins in hepatocytes. J Infect Dis 2006;194:670-81.
14. Sironi JJ, Ouchi T. STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem 2004;279:4066-74.
15. Nguyen H, Lin R, Hiscott J. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene 1997;15:1425-35.
16. Lee CK, Smith E, Gimeno R, Gertner R, Levy DE. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J Immunol 2000;164:1286-92.
17. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006;6:836-48.
18. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005;2:92-100.
19. Danial NN, Rothman P. JAK-STAT signaling activated by Abl oncogenes. Oncogene 2000;19:2523-31.
20. Park ES, Kim H, Suh JM, et al. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Mol Endocrinol 2000;14:662-70.
21. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A 2001;98:9050-5.
22. Lee MY, Joung YH, Lim EJ, et al. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 2006;15:187-95.
23. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 2005;280:8714-21.
24. Pedersen MW, Pedersen N, Damstrup L, et al. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation. J Cell Biochem 2005;96:412-27.
25. Kirito K, Nakajima K, Watanabe T, et al. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood 2002;99:102-10.
26. Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G, Schmidt-Ullrich RK. Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell 2002;13:2233-44.
27. Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A 2004;101:1714-9.
28. Salloum RM, Jaskowiak NT, Mauceri HJ, et al. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res 2000;60:6958-63.
29. Khodarev NN, Yu J, Nodzenski E, et al. Method of RNA purification from endothelial cells for DNA array experiments. Biotechniques 2002;32:316-20.
30. Hallahan DE, Mauceri HJ, Seung LP, et al. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1995;1:786-91.
31. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999;96:9212-7.
32. Ramana CV, Gil MP, Schreiber RD, Stark GR. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol 2002;23:96-101.
33. Klampfer L, Huang J, Corner G, et al. Oncogenic Kiras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. J Biol Chem 2003;278:46278-87.
34. Hall EJ. Radiobiology for radiologist. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 32-51.
35. Weichselbaum RR, Beckett MA, Vijayakumar S, et al. Radioresistant tumor cell lines derived from head and neck radiation failures. Head Neck 1989;11:343-8.
36. Amundson SA, Grace MB, McLeland CB, et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 2004;64:6368-71.
37. Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 2003;13:2092-100.
38. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
39. Jechlinger M, Sommer A, Moriggl R, et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 2006;116:1561-7.
40. Timofeeva OA, Plisov S, Evseev AA, et al. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 2006;25:7555-64.
41. Kita K, Sugaya S, Zhai L, et al. Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays. Radiat Res 2003;160:302-8.
42. Steiner E, Holzmann K, Pirker C, et al. The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals. J Cell Sci 2006;119:459-69.
43. Malakhova OA, Yan M, Malakhov MP, et al. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 2003;17:455-60.
44. Friedberg JW, Dong DA, Li S, et al. Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. Leuk Res 2004;28:139-47.
45. Thomas M, Finnegan CE, Rogers KM, et al. STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res 2004;64:8357-64.
46. Roberts D, Schick J, Conway S, et al. Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br J Cancer 2005;92:1149-58.
47. Rickardson L, Fryknas M, Dhar S, et al. Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer 2005;93:483-92.
48. Fryknas M, Dhar S, Oberg F, et al. STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer 2007;120:189-95.
49. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003;3:745-56.
50. Beyaert R, Van Loo G, Heyninck K, Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 2002;214:225-72.
51. Lin HK, Bergmann S, Pandolfi PP. Deregulated TGF-β signaling in leukemogenesis. Oncogene 2005;24:5693-700.
52. Tsai M-H, Cook JA, Chandramouli GVR, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007;67:3845-52.